Furthermore, VEGF-A levels positively associate with infiltration of CD8+ T cells, macrophages, and other immune cells within the tumor microenvironment, highlighting its dual function as a prognostic biomarker and potential therapeutic target in RCC [89]. Here, VEGFA is linked to renal cell carcinoma.